Home > Insider Trading > Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp. (MRK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
591 - 600
Next >>

Here's What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why It's So Important

OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical giant Merck & Co., Inc. (NYSE:MRK).

Keep Reading →

November 17th, 2016 - News Stock Analysis

Apple Inc. (AAPL), Alphabet Inc (GOOGL), More: See What This $36 Billion Hedge Fund Was Buying in Q3

Adage Capital Management is a Boston-based hedge fund founded in 2001 by Phil Gross and Robert Atchinson. As of June 30, Adage’s public equity portfolio has a worth of $36.31 billion.

Keep Reading →

November 15th, 2016 - Hedge Fund Analysis Hedge Funds News

5 Healthcare Stocks Kahn Brothers Is Bullish On

Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager) in 1978.

Keep Reading →

November 8th, 2016 - Hedge Fund Analysis Hedge Funds News

FDA Approves Merck & Co., Inc. (MRK) Keytruda For NSCLC

The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc.

Keep Reading →

October 26th, 2016 - News Stock Analysis

Merck & Co. Inc. (MRK) Shuts Down Florida Facility

The pharmaceutical giant intends to lay off employees in two waves, the first of which is set next month and the other one in December.

Keep Reading →

October 6th, 2016 - News Stock Analysis

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process for licensure of Ebola vaccines...

Keep Reading →

August 29th, 2016 - News Stock Analysis

Bourgeon Capital Management Reveals Top Picks for Q3, With JPMorgan Chase & Co. (JPM) Leading the Pack

Bourgeon Capital Management LLC, founded by John A.

Keep Reading →

August 3rd, 2016 - Hedge Fund Analysis Hedge Funds News

Trending Stocks: Xerox, LyondellBasell, Enbridge, and 2 More

U.S. stock futures are flat this morning following a decline in crude prices over worries surrounding renewed oversupply.

Keep Reading →

July 29th, 2016 - Earnings Report Market Movers News

Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK)

On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc. (NYSE:MRK) monoclonal antibody drug designed to prevent recurrence of C.

Keep Reading →

July 22nd, 2016 - News Stock Analysis

Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape

Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually on a hunch.

Keep Reading →

July 19th, 2016 - News Stock Analysis